Use of aldosterone antagonists at discharge after myocardial infarction: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry–Get with the Guidelines (GWTG)
Krishnasree Rao(The University of Texas Southwestern Medical Center), Sandeep R. Das, Karen P. Alexander(Clinical Research Institute), Gregg C. Fonarow(UCLA Medical Center), Anita Y. Chen(University of Rochester Medicine), Jonathan Enriquez(Saint Luke's Hospital), Darren K. McGuire(Parkland Health & Hospital System), James A. de Lemos(Universität Hamburg)
Cited by 29
Related Papers
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k